This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varga, J.
Right arrow Articles by Samson, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varga, J.
Right arrow Articles by Samson, R. A.

 Previous Article  |  Next Article 

Eukaryotic Cell, April 2008, p. 630-638, Vol. 7, No. 4
1535-9778/08/$08.00+0     doi:10.1128/EC.00425-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Aspergillus calidoustus sp. nov., Causative Agent of Human Infections Previously Assigned to Aspergillus ustus{triangledown}

János Varga,1,2 Jos Houbraken,1 Henrich A. L. Van Der Lee,3 Paul E. Verweij,3 and Robert A. Samson1*

CBS Fungal Biodiversity Centre, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands,1 Department of Microbiology, Faculty of Science and Informatics, University of Szeged, H-6701 Szeged, P.O. Box 533, Hungary,2 Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen University Center for Infectious Diseases, P.O. Box 9101 6500 HB, Nijmegen, The Netherlands3

Received 20 November 2007/ Accepted 7 February 2008

Aspergillus ustus is a relatively rare human pathogen causing invasive infections in immunocompromised hosts. In this study isolates originating from clinical and other sources have been examined using molecular, morphological, and physiological approaches to clarify their species assignment. Phylogenetic analysis of partial β-tubulin, calmodulin, actin, and intergenic transcribed spacer sequences indicated that none of the clinical isolates recognized previously as A. ustus belongs to this species. All but two of these isolates formed a well-defined clade related to A. pseudodeflectus based on sequence analysis of protein-coding regions. Morphological and physiological examination of these isolates indicated that they are able to grow above 37°C, in contrast with A. ustus isolates, and give a positive Ehrlich reaction, in contrast with related species including A. granulosus, A. ustus, and A. pseudodeflectus. These isolates are proposed as a new species, A. calidoustus. Antifungal susceptibility testing showed that this species has decreased susceptibilities to several antifungal drugs. The triazoles are inactive in vitro, including the new azole posaconazole.


* Corresponding author. Mailing address: CBS Fungal Biodiversity Centre, P.O. Box 85167, 3508 AD Utrecht, The Netherlands. Phone: 31 30 2122600. Fax: 31 30 2512097. E-mail: r.samson{at}cbs.knaw.nl

{triangledown} Published ahead of print on 15 February 2008.


Eukaryotic Cell, April 2008, p. 630-638, Vol. 7, No. 4
1535-9778/08/$08.00+0     doi:10.1128/EC.00425-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Balajee, S. A., Kano, R., Baddley, J. W., Moser, S. A., Marr, K. A., Alexander, B. D., Andes, D., Kontoyiannis, D. P., Perrone, G., Peterson, S., Brandt, M. E., Pappas, P. G., Chiller, T. (2009). Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network. J. Clin. Microbiol. 47: 3138-3141 [Abstract] [Full Text]  
  • Baddley, J. W., Marr, K. A., Andes, D. R., Walsh, T. J., Kauffman, C. A., Kontoyiannis, D. P., Ito, J. I., Balajee, S. A., Pappas, P. G., Moser, S. A. (2009). Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network. J. Clin. Microbiol. 47: 3271-3275 [Abstract] [Full Text]  
  • Sutton, D. A., Wickes, B. L., Romanelli, A. M., Rinaldi, M. G., Thompson, E. H., Fothergill, A. W., Dishop, M. K., Elidemir, O., Mallory, G. B., Moonnamakal, S. P., Adesina, A. M., Schecter, M. G. (2009). Cerebral Aspergillosis Caused by Aspergillus granulosus. J. Clin. Microbiol. 47: 3386-3390 [Abstract] [Full Text]  
  • Verweij, P. E., Maertens, J. (2009). Moulds: diagnosis and treatment. J Antimicrob Chemother 63: i31-i35 [Abstract] [Full Text]  
  • Balajee, S. A., Borman, A. M., Brandt, M. E., Cano, J., Cuenca-Estrella, M., Dannaoui, E., Guarro, J., Haase, G., Kibbler, C. C., Meyer, W., O'Donnell, K., Petti, C. A., Rodriguez-Tudela, J. L., Sutton, D., Velegraki, A., Wickes, B. L. (2009). Sequence-Based Identification of Aspergillus, Fusarium, and Mucorales Species in the Clinical Mycology Laboratory: Where Are We and Where Should We Go from Here?. J. Clin. Microbiol. 47: 877-884 [Full Text]  
  • Etienne, K. A., Kano, R., Balajee, S. A. (2009). Development and Validation of a Microsphere-Based Luminex Assay for Rapid Identification of Clinically Relevant Aspergilli. J. Clin. Microbiol. 47: 1096-1100 [Abstract] [Full Text]  
  • Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., Diekema, D. J. (2008). In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species. J. Clin. Microbiol. 46: 2568-2572 [Abstract] [Full Text]